| 000 | 01808 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514211045.0 | ||
| 264 | 0 | _c20050214 | |
| 008 | 200502s 0 0 eng d | ||
| 022 | _a0176-3679 | ||
| 024 | 7 |
_a10.1055/s-2004-832685 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKühn, K-U | |
| 245 | 0 | 0 |
_aNeuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor. _h[electronic resource] |
| 260 |
_bPharmacopsychiatry _cNov 2004 |
||
| 300 |
_a286-91 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnxiety _xdrug therapy |
| 650 | 0 | 4 |
_aBrain _xanatomy & histology |
| 650 | 0 | 4 | _aBrain Mapping |
| 650 | 0 | 4 |
_aCerebrovascular Circulation _xdrug effects |
| 650 | 0 | 4 |
_aCysteine _xmetabolism |
| 650 | 0 | 4 | _aDemography |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImage Processing, Computer-Assisted _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2C _xgenetics |
| 650 | 0 | 4 |
_aSerine _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin Receptor Agonists _xpharmacology |
| 650 | 0 | 4 | _aTechnetium Tc 99m Exametazime |
| 650 | 0 | 4 |
_aTomography, Emission-Computed, Single-Photon _xmethods |
| 700 | 1 | _aJoe, A Y | |
| 700 | 1 | _aMeyer, K | |
| 700 | 1 | _aReichmann, K | |
| 700 | 1 | _aMaier, W | |
| 700 | 1 | _aRao, M L | |
| 700 | 1 | _aReinhardt, M J | |
| 700 | 1 | _aBiersack, H-J | |
| 700 | 1 | _aQuednow, B B | |
| 773 | 0 |
_tPharmacopsychiatry _gvol. 37 _gno. 6 _gp. 286-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2004-832685 _zAvailable from publisher's website |
| 999 |
_c15237393 _d15237393 |
||